Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis
Open Access
- 1 July 2000
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 69 (1) , 121-123
- https://doi.org/10.1136/jnnp.69.1.121
Abstract
Sialorrhoea is a socially disabling problem in bulbar amyotrophic lateral sclerosis (ALS). Botulinum toxin A (BoNT/A) was injected into the salivary glands in five patients with bulbar ALS and sialorrhoea. The effect of BoNT/A was measured by the number of paper handkerchiefs used each day and by salivary gland scintigraphy. BoNT/A ameliorated sialorrhoea and quality of life without major adverse effects. BoNT/A may be a relatively safe and effective treatment for sialorrhoea in selected patients.Keywords
This publication has 9 references indexed in Scilit:
- Botulinum Toxin in the Treatment of Neurological Disorders of the Autonomic Nervous SystemArchives of Neurology, 1999
- Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the ratEuropean Archives of Oto-Rhino-Laryngology, 1999
- Botulinum Toxin Decreases Salivation from Canine Submandibular GlandsOtolaryngology -- Head and Neck Surgery, 1998
- Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glandsMedical Hypotheses, 1997
- Botulinum toxin for palmar hyperhidrosisThe Lancet, 1997
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25Nature, 1993
- The Management of Motor Neurone DiseasePublished by Springer Nature ,1987
- Effect of botulinum toxin on the choline acetyltransferase activity in salivary glands of catsCellular and Molecular Life Sciences, 1977